CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrix.


Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 27 01 2020
accepted: 03 04 2020
pubmed: 11 4 2020
medline: 26 9 2020
entrez: 11 4 2020
Statut: ppublish

Résumé

Abnormal development of the ocular anterior segment may lead to a spectrum of clinical phenotypes ranging from primary congenital glaucoma (PCG) to variable anterior segment dysgenesis (ASD). The main objective of this study was to identify the genetic alterations underlying recessive congenital glaucoma with ASD (CG-ASD). Next-generation DNA sequencing identified rare biallelic CPAMD8 variants in four patients with CG-ASD and in one case with PCG. CPAMD8 is a gene of unknown function and recently associated with ASD. Bioinformatic and in vitro functional evaluation of the variants using quantitative reverse transcription PCR and minigene analysis supported a loss-of-function pathogenic mechanism. Optical and electron microscopy of the trabeculectomy specimen from one of the CG-ASD cases revealed an abnormal anterior chamber angle, with altered extracellular matrix, and apoptotic trabecular meshwork cells. The CPAMD8 protein was immunodetected in adult human ocular fluids and anterior segment tissues involved in glaucoma and ASD (i.e., aqueous humor, non-pigmented ciliary epithelium, and iris muscles), as well as in periocular mesenchyme-like cells of zebrafish embryos. CRISPR/Cas9 disruption of this gene in F0 zebrafish embryos (96 hpf) resulted in varying degrees of gross developmental abnormalities, including microphthalmia, pharyngeal maldevelopment, and pericardial and periocular edemas. Optical and electron microscopy examination of these embryos showed iridocorneal angle hypoplasia (characterized by altered iris stroma cells, reduced anterior chamber, and collagen disorganized corneal stroma extracellular matrix), recapitulating some patients' features. Our data support the notion that CPAMD8 loss-of-function underlies a spectrum of recessive CG-ASD phenotypes associated with extracellular matrix disorganization and provide new insights into the normal and disease roles of this gene.

Identifiants

pubmed: 32274568
doi: 10.1007/s00439-020-02164-0
pii: 10.1007/s00439-020-02164-0
doi:

Substances chimiques

CPAMD8 protein, human 0
Complement C3 0
alpha-Macroglobulins 0
Trypsin Inhibitor, Kazal Pancreatic 50936-63-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1209-1231

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI15/01193, PI19/00208 and RD16/0008/0019, OFTARED
Organisme : Instituto de Salud Carlos III
ID : RD16/0008/0004, OFTARED
Organisme : Instituto de Salud Carlos III
ID : RD16/0008/0005, OFTARED
Organisme : Instituto de Salud Carlos III
ID : PI17_01164
Organisme : Instituto de Salud Carlos III
ID : CIBERER 06/07/0036
Organisme : Ministerio de Economía y Competitividad
ID : SAF2013-46943
Organisme : Consejería de educacion de Castilla-La Mancha
ID : SBPLY/17/180501/000404
Organisme : Ramon Areces Foundation and Regional Government of Madrid
ID : CAM, B2017/BMD3721

Auteurs

Juan-Manuel Bonet-Fernández (JM)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.

José-Daniel Aroca-Aguilar (JD)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.

Marta Corton (M)

Área de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Ana-Isabel Ramírez (AI)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain.

Susana Alexandre-Moreno (S)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.

María-Teresa García-Antón (MT)

Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain.

Juan-José Salazar (JJ)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain.

Jesús-José Ferre-Fernández (JJ)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.

Raquel Atienzar-Aroca (R)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.

Cristina Villaverde (C)

Área de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Ionut Iancu (I)

Área de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Alejandra Tamayo (A)

Área de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.

Carmen-Dora Méndez-Hernández (CD)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Servicio de Oftalmología, Hospital San Carlos, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.

Laura Morales-Fernández (L)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Servicio de Oftalmología, Hospital San Carlos, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.

Blanca Rojas (B)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain.
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Carmen Ayuso (C)

Área de Genética and Genómica, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

Miguel Coca-Prados (M)

Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.

José-Maria Martinez-de-la-Casa (JM)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Servicio de Oftalmología, Hospital San Carlos, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.

Julián García-Feijoo (J)

Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain.
Servicio de Oftalmología, Hospital San Carlos, Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.

Julio Escribano (J)

Área de Genética, Facultad de Medicina de Albacete, Universidad de Castilla-La Mancha, Albacete, Spain. julio.escribano@uclm.es.
Instituto de Investigación en Discapacidades Neurológicas (IDINE), Universidad de Castilla-La Mancha, Albacete, Spain. julio.escribano@uclm.es.
Cooperative Research Network on Age-Related Ocular Pathology, Visual and Life Quality (OFTARED), Instituto de Salud Carlos III, Madrid, Spain. julio.escribano@uclm.es.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH